Walbert Timothy P
SEC-identified person · CIK 1349376 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Kardigan, Inc. KARD | Director | filed 2026–2026 |
| Mirum Pharmaceuticals, Inc. MIRM | Director | filed 2023–2026 |
| Biomarin Pharmaceutical INC BMRN | Director | filed 2025–2026 |
| Odyssey Therapeutics, Inc. ODTX | Director | filed 2026–2026 |
| Century Therapeutics, Inc. IPSC | Director | filed 2022–2025 |
| Sagimet Biosciences Inc. SGMT | Director | filed 2024–2025 |
| Horizon Therapeutics Public Ltd Co HZNP | Director · President, Chairman and CEO | filed 2011–2023 |
| Aurinia Pharmaceuticals Inc. AUPH | Director | filed 2021–2022 |
| Max-1 Acquisition Corp XCUR | Director | filed 2019–2021 |
| Assertio Holdings, Inc. ASRT | Director | filed 2020–2020 |
| Zyla Life Sciences ZCOR | Director | filed 2014–2020 |
| Sucampo Pharmaceuticals, Inc. SCMP | Director | filed 2015–2018 |
| Xoma Royalty Corp XOMAD | Director | filed 2010–2017 |
| Torreypines Therapeutics, Inc. TPTX | Director | filed 2011–2014 |
| IDM Pharma, INC. idmi | Director · President,CEO | filed 2007–2008 |
| Neopharm INC NEOL.PK | Ex. VP Comm.Ops | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.